Rosiglitazone enhances the radiosensitivity of p53-mutant HT-29 human colorectal cancer cells.

Rosiglitazone enhances the radiosensitivity of p53-mutant HT-29 human colorectal cancer cells.

Year2010
AuthorShu-Jun Chiu*, Ching-Hui Hsaio, Ho-Hsing Tseng, Yu-Han Su, 施玟玲, Jeng-Woei Lee, Jennifer Qui-Yu Chuah
Author count7
Created date2019-02-19
Author order第四(以上)作者
Corresponding author
Publication year2010
Publication month4
Journal nameBiochemical and Biophysical Research Communications
Publication area中華民國
Issue394
Start page774
End page779
Publication type
Review system
LanguageForeign Language
Attached project